Stacy Loeb, Scott W Keith, Heather H Cheng, Amy E Leader, Laura Gross, Tatiana Sanchez Nolasco, Nataliya Byrne, Rebecca Hartman, Lauren H Brown, Christopher Michael Pieczonka, Leonard G Gomella, William Kevin Kelly, Costas D Lallas, Nathan Handley, Patrick Johnston Mille, James Ryan Mark, Gordon Andrew Brown, Sameer Chopra, Alexandra McClellan, David R Wise, Lucas Hollifield, Veda N Giri
PURPOSE: Germline genetic testing (GT) is important for prostate cancer (PCA) management, clinical trial eligibility, and hereditary cancer risk. However, GT is underutilized and there is a shortage of genetic counselors. To address these gaps, a patient-driven, pretest genetic education webtool was designed and studied compared with traditional genetic counseling (GC) to inform strategies for expanding access to genetic services. METHODS: Technology-enhanced acceleration of germline evaluation for therapy (TARGET) was a multicenter, noninferiority, randomized trial (ClinicalTrials...
March 2024: JCO Precision Oncology